logo-loader

Richard Goodfellow Presents on Behalf of Scancell at the Biotech Capital Conference

Published: 03:57 08 Mar 2016 EST

Richard Goodfellow Presents on Behalf of Scancell at the Biotech Capital Conference 

Scancell CEO hails "exciting" high response rate to melanoma treatment

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the initial phase of the clinical stage biopharmaceutical company's Phase 2 SCOPE trial in advanced melanoma. Professor Durrant gives an overview...

on 09/19/2023